Organthis is a biotech startup pioneering the future of personalized medicine. We develop and scale advanced organoid technologies, combining them with AI-powered analytics to transform drug testing and therapeutic development.
At the core of our innovation is OrganMatch, our proprietary platform that enables personalized, predictive medicine by testing drugs on patient-specific organoid models. This approach not only reduces risk and cost in pharma R&D, but also promises safer, more effective treatments tailored to individual biology.
We believe in a future where medicine is not one-size-fits-all. Our mission is to bridge the gap between cutting-edge research and real-world healthcare by making organoid-based, AI-supported testing a clinical standard.
Company Details
- Employees
- 2
- Address
- Villefortgasse 11, Graz,8010,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://organthis.com
- Keywords
- Fontenay-aux-Roses.
- HQ
- Graz
Organthis Questions
Organthis's website is https://organthis.com
Organthis's LinkedIn profile is https://at.linkedin.com/company/organthis
Organthis has
2 employees.
View email and phone details for 2
employees at Organthis.
Organthis's industry is
Biotechnology Research
Organthis's top competitors are
S2nano : Safe And Sustainable Nano,
The Organoid Company,
Omnibios Inc.,
_msr Studio,
The Reprefred Society - Austrian 3r Center (A3rc),
Neuratris,
Akte Therapeutics,
Ualise,
Lab-Grown Leather Ltd,
Empowered By Us.
Organthis's categories are Biotechnology Research
